Ledger.Open graph →
SEC Form D · filed February 27, 2024

eGenesis, Inc

Offering
$28.7M
Sold
$25.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Steven Gillis · Ann Arbor, MIDirectorAlbert Wiegman · San Antonio, TXDirectorSarah Schlesinger · CAMBRIDGE, MADirectorMark Pruzanski · CAMBRIDGE, MADirectorBrad Smith · Southfield, MIDirectorRahul Kakkar · Cambridge, MADirectorJulie Sunderland · Seattle, WADirectorMichael Curtis · New York, NYExec · DirectorJennifer Bergheiser · CAMBRIDGE, MAExecPaul Sekhri · Rockville, MDDirectorLucio Iannone · Boston, MADirectorKathleen Fanning · Seattle, WADirectorSarah Schlesinger · CAMBRIDGE, MADirectorMark Pruzanski · CAMBRIDGE, MADirectorBrad Smith · Nashville, TNDirectorSteven Gillis · Chicago, ILDirectorRahul Kakkar · Cambridge, MADirectorAlbert Wiegman · Needham, MADirectorJulie Sunderland · Seattle, WADirectorMichael Curtis · Saint-Eustache, Quebec, CanadaExec · DirectorJennifer Bergheiser · CAMBRIDGE, MAExecPaul Sekhri · Ann Arbor, MIDirectorLucio Iannone · Branford, CTDirectorKathleen Fanning · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗